How And Where Tougher Clinical Evaluation Measures Under EU MDR Cause Challenges
A first of its kind study examines how large compared with medium companies are coping with the EU’s strict clinical evidence requirements. The results show how it is the more stringent demands for high-risk devices that are leading to device removals as well as market launch outside the EU.
You may also be interested in...
With so many regulatory developments happening concurrently in the EU at present, five forthcoming conferences promise delegates a timely update and vibrant discussions.
With so much discussion now on the need for fundamental change in the future regulation of medtech products in the EU, Medtech Insight reflects on lessons to be learnt.
The EU medtech industry is calling for an update to the decades-old rules on electronic IFU for devices. A glimpse at the listings in the European Commission’s recently released table of member state language requirements reflects how punitive the demand for hard-copy IFU can be.